Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial

MLA

Javier Sastre, et al. Genotype-Based Selection of Treatment of Patients with Advanced Colorectal Cancer (SETICC): A Pharmacogenetic-Based Randomized Phase II Trial. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f3a98bf55f4cf2204fc2a4fcea6edd8&authtype=sso&custid=ns315887.

APA

Javier Sastre, Cristina Grávalos, B. Massuti, Albert Abad, V. Alonso-Orduna, Ramon Salazar, Eva Martinez-Balibrea, Enrique Aranda, C. Montagut, Javier Gallego, Mariano Provencio, Alfredo Carrato, M. Zanui, F. Rivera, Manuel Valladares-Ayerbes, Jose Luis Manzano, P. García Alfonso, Manuel Benavides, V. Conde, & Jose María Vieitez. (2018). Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Chicago

Javier Sastre, Cristina Grávalos, B. Massuti, Albert Abad, V. Alonso-Orduna, Ramon Salazar, Eva Martinez-Balibrea, et al. 2018. “Genotype-Based Selection of Treatment of Patients with Advanced Colorectal Cancer (SETICC): A Pharmacogenetic-Based Randomized Phase II Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2f3a98bf55f4cf2204fc2a4fcea6edd8&authtype=sso&custid=ns315887.